GHRP-2 and GHRP-6 Compared

For laboratory research use only. Not for human or veterinary use.

GHRP-2 and GHRP-6 are asked about together more than almost any other pair of research peptides, and most of what is written about them online compares vague impressions rather than the two molecules. This guide sets out what each one actually is — sequence, formula, mass, receptor — where the structural difference lies, and what that difference does and does not mean.

What they have in common

Both are synthetic hexapeptides: six amino acids, chemically manufactured rather than extracted. Both belong to the class known as growth hormone secretagogues, and both act as agonists at the growth hormone secretagogue receptor (GHS-R), now more commonly called the ghrelin receptor.

Both descend from the same line of work. They were developed from synthetic analogues of met-enkephalin, an endogenous opioid peptide, in a research programme that ran through the 1980s. The finding that drove the field was that certain enkephalin-derived structures stimulated growth hormone release through a receptor entirely separate from the one growth hormone-releasing hormone uses — a second, independent pathway. The receptor those compounds were binding was identified before its natural ligand was. Ghrelin, the endogenous molecule that occupies it, was not characterised until 1999.

That history is why both compounds are sometimes described as ghrelin mimetics: they were found first and explained afterwards.

Side by side

The two molar masses are 55 g/mol apart. That matters practically: a mass spectrum is the quickest way to tell which compound is actually in the vial, and the two are far enough apart that there is no ambiguity.

Where the structures diverge

Look at positions one and two. Everything from position three onward — Ala-Trp-D-Phe-Lys-NH₂ — is identical.

• GHRP-6 opens with histidine, then D-tryptophan.
• GHRP-2 opens with D-alanine, then D-2-naphthylalanine.

D-2-Nal is not one of the twenty amino acids biology uses. It is a synthetic residue carrying a naphthalene ring — two fused aromatic rings in place of tryptophan's single indole. Substituting it does two things at once: it enlarges the hydrophobic contact the molecule makes with the receptor pocket, and because no endogenous protease is evolved to cut next to a non-natural residue, it slows enzymatic breakdown.

That single substitution is most of the difference between the two compounds. GHRP-2 is the more potent of the pair at the receptor, milligram for milligram, and this is the structural reason why.

The appetite difference

The other commonly cited distinction is that GHRP-6 is associated with a markedly stronger appetite signal in the published literature, while GHRP-2's effect on the same pathway is reported as weaker.

This is not a side effect in the pharmacological sense — it is the ghrelin pathway doing exactly what it does. Ghrelin is the body's own hunger signal, and any compound occupying its receptor engages that signalling alongside growth hormone release. The two effects share a receptor; separating them is a matter of degree, not of mechanism.

For research design, this is the practical consequence: the two compounds are not interchangeable controls for each other. If the pathway under study intersects with appetite regulation, the choice between them changes what you are measuring.

Why “which is better” is usually the wrong question

Most comparisons of these two compounds are framed as a ranking. That framing does not survive contact with the pharmacology, because they are the same mechanism at different potencies with different secondary weighting on a shared pathway. Neither is a stronger version of the other; they occupy different positions on the same axis.

The useful questions are narrower. Which receptor interactions does the study need to isolate? Does appetite signalling confound the measurement or form part of it? Is potency per milligram a variable that matters here, or is molar equivalence being controlled for anyway? Those have answers. “Which is better” does not.

What to check on the certificate

Both compounds are manufactured by solid-phase synthesis and both are supplied as a lyophilised powder, which means the certificate matters more than the label. Four things are worth reading on any batch document for either compound.

• Mass spectrometry. The observed mass should correspond to the molar mass in the table above. This is the identity check, and it is the one that distinguishes GHRP-2 from GHRP-6 unambiguously.
• HPLC purity. Reported as measured on that batch, with the method named. A figure with no method behind it is a number, not a result.
• Net peptide content. Distinct from purity, and routinely conflated with it. A lyophilised peptide carries counter-ions and residual water; net peptide content is how much of the vial mass is peptide. A batch can be highly pure and still be substantially salt.
• Counter-ion. Usually acetate or trifluoroacetate, from the purification step. Which one it is affects the net peptide figure and, for some assays, the result.

Pioneer publishes the certificate for each tested batch in full, with its verification key, in the COA library. Our guides on how to read a COA and what a purity figure actually means go through each of these in detail.

Handling and storage

Both compounds behave the same way in storage, which simplifies matters if you hold both.

As a lyophilised powder, sealed and kept cold and dark, either is stable for a long period — this is the reason peptides are freeze-dried in the first place. Once in solution, that changes: stability drops sharply, and the material becomes sensitive to temperature, light, repeated freeze-thaw cycles and time. The storage guide covers the conditions in detail, and the reconstitution guide covers returning the powder to solution without degrading it.

Both are tryptophan-containing peptides, which makes light protection more than a formality — tryptophan is among the more photosensitive residues, and an amber vial or foil wrap is a reasonable default for either.

What Pioneer supplies

Both compounds are stocked as 5mg lyophilised vials at the same price, tested by an independent laboratory, with the batch certificate available on request. They ship from the UK with same-day dispatch on orders before 2pm, alongside the bacteriostatic or sterile water and transfer equipment to work with them.

Quality comes first

Comparing two compounds is only meaningful if each vial contains what its label says. Pioneer compounds are tested by an independent laboratory, and the certificate for each tested batch is published in full with its verification key in the COA library, so you can check the documentation for the vial before it reaches your bench rather than after. The certificate for your batch is also available on request.

Pioneer Research Peptides — UK supplier of research peptides for laboratory use. Independently tested by batch, certificates published with verification keys at the COA library.

For laboratory research use only — not for human consumption. 18+.